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Abstract
Background: While in general practice chronic non-specific abdominal complaints are common,
there is insufficient data on the clinical course and the management of these complaints. Aim of this
study was to present a primary care based profile of these chronic complaints including health care
involvement, health status and clinical course.
Methods: Thirty general practitioners (GPs) and patients from their practices participated in a
prospective follow-up study. All patients and GPs were asked to complete questionnaires at
baseline and at 6, 12 and 18 months of follow-up. The GPs provided information on diagnostic and
therapeutic management and on referral concerning 619 patients with chronic non-specific
abdominal complaints, while 291 patients provided information about health status and clinical
course of the complaints.
Results: When asked after 18 months of follow-up, 51,7% of the patients reported an equal or
worsened severity of complaints. General health perception was impaired and patients had high
scores on SCL-anxiety and SCL-depression scales. Diagnostic tests other than physical examination
and laboratory tests were not frequently used. Medication was the most frequent type of
treatment. The persistence of chronic non-specific abdominal complaints was quite stable.
Conclusion: Once non-specific chronic abdominal complaints have become labelled as chronic by
the attending physician, little improvement can be expected. The impact on patients' physiological
and psychological well-being is large. GPs use a variety of diagnostic and therapeutic strategies.
Research into the evidence base of currently applied management strategies is recommended.
Background
Patients with non-specific abdominal complaints com-
prise a large proportion of primary care and gastroenterol-
ogy practice [1-6]. Annually 15 out of every 1000
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new abdominal complaints [7]. Since chronic non-spe-
cific abdominal complaints are mainly managed by the
GP, it is of importance to know how general practitioners
deal with these complaints, especially since results, con-
cerning management and prognosis, from more selected,
e.g. hospital based, populations cannot be generalised to
primary care [8]. Data on diagnostic and therapeutic strat-
egies chosen in primary care are of importance for the
development of tailor-made guidelines for the manage-
ment of these complaints. However, despite this impor-
tance, little detailed data are available. Also, the clinical
course of chronic non-specific abdominal complaints in
general practice is not well documented. Reviews showed
that no studies have been carried out on the clinical
course of irritable bowel syndrome (IBS) in primary care
[9] and that only 3 studies on the clinical course of non-
ulcer dyspepsia (NUD) in primary care were performed
[10].
In summary, the understanding of the management and
the course of non-specific abdominal complaints in fam-
ily practice seems to be rather poor. The aim of this study
is to present a primary care based profile of chronic non-
specific abdominal complaints in family practice includ-
ing health care involvement, patients' perspective and
clinical course.
The following research questions were formulated:
1. What is the health care involvement regarding patients
with chronic non-specific abdominal complaints in pri-
mary care, including GP-visits, diagnostic and therapeutic
management and referrals?
2. What is the course of the complaints and what are its
determinants?
3. Do IBS, NUD and other abdominal complaints differ
with respect to the former two questions?
Methods
• Patients and procedures
The GPs and patients who participated in this study were
recruited from the Registration Network Family Practices
(RNH) of the Maastricht University in the Netherlands
[11]. The Registration Network provides a computerised
anonymous database containing certain patient character-
istics and relevant health problems. Health problems are
defined as 'anything that has required, does or may
require health care management and has affected or could
significantly affect a persons physical or emotional well-
being'. The RNH GPs only register permanent problems
(no recovery expected), chronic problems (duration
longer than six months) and/or recurrent problems (more
than three recurrences within a six-month period). The
health problems are coded using the International Classi-
fication of Primary Care (ICPC) [12] using diagnostic cri-
teria based on the International Classification of Health
Problems in Primary Care (ICHPPC-2) [13]. All informa-
tion concerning each patient including data on diagnostic
and therapeutic modalities are stored in electronic medi-
cal records in chronological sequence. The general practi-
tioners continuously update the patient characteristics
and problem lists of all their registered patients. The
patient population is very similar to the Dutch general
population regarding age, gender, type of health insur-
ance and level of education [14].
From the RNH database potentially eligible patients were
identified using five relevant ICPC codes:
1. Abdominal pain without organic explanation (ICPC
codes D01, D02 and D06) and/or
2. Non-ulcer dyspepsia (ICPC code D87) and/or
3. Irritable bowel syndrome (ICPC code D93)
The purpose of this process was to select a cohort of
patients with chronic non-specific abdominal complaints
in general practice. The patients were registered with a
total of 30 GPs working in 16 practices.
Patients were included on the basis of the following crite-
ria: 1) abdominal pain without organic explanation and/
or non-ulcer dyspepsia and/or irritable bowel syndrome
(ICPC codes D01, D02, D06, D87 or D93), 2) at baseline,
symptoms had to be present for at least six months, 3)
there was no evidence of an organic cause of the symp-
toms and 4) patients had to be 18–70 years of age.
Patients were excluded when there was a malignancy of
the gastrointestinal tract.
Eligible patients were invited by their GP to participate in
the study. The GP and the first author checked in- and
exclusion criteria.
All patients and GPs were asked to complete a question-
naire at baseline and after 6, 12 and 18 months. The base-
line questionnaire covered the previous 12 months and
each follow-up questionnaire covered the previous 6
months.
• Instruments
The GP questionnaires covered variables such as age, gen-
der, diagnosis, comorbidity, diagnostic modalities, thera-
peutic interventions and new referrals to specialists for the
complaints at issue.Page 2 of 8
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duration, localisation, frequency and severity of the com-
plaints. Global subjective improvement was categorised
in: improvement versus no improvement and/or worsen-
ing as stated by the patient concerning the previous 6
month-period. The severity of the abdominal pain was
measured on an 11-point ordinal scale ranging from 0 (no
pain) to 10 (very severe pain).
The Nottingham Health Profile (NHP) was used to assess
the general health perception. The first section of the NHP
was used, consisting of 6 categories: energy, pain, emo-
tional reactions, sleep, physical mobility and social isola-
tion. Higher scores indicate more health problems. The
original versions of the NHP and the Dutch translation
have been demonstrated to be both reliable and valid.
[15,16]
Subscales of the Symptom Checklist 90 (SCL-90) were
used to assess depression and anxiety. Higher scores indi-
cate more mental health problems. The original versions
of the SCL-90 as well as the Dutch translation have both
been shown to be valid and reliable [17,18].
The Gastrointestinal Symptom Rating Scale (GSRS) was
used to assess the severity of gastrointestinal symptoms.
The GSRS includes 15 items and uses a 7-graded Likert
scale, where 1 presents the most positive option and 7 the
most negative one. The higher the scores, the more pro-
nounced are the symptoms. The items have been grouped
in 5 dimensions: indigestion syndrome, diarrhoea syn-
drome, obstipation syndrome, abdominal pain syndrome
and reflux syndrome. The original English version of the
rating scale is interview-based. For the present study it was
translated into Dutch and modified into a self-adminis-
tered questionnaire. The original (English) version of the
GSRS has been demonstrated to be reliable and valid
[19,20].
• Statistics
Descriptive statistics were used to present the course of
complaints (pain intensity, global improvement, number
of visits, NHP, SCL and GSRS), the frequencies of diagnos-
tic and therapeutic interventions and the referrals over the
18-month follow-up.
Differences between subgroups were analysed by using
the Chi-square test statistic (for categorical variables), the
Student t test statistic (for continuous variables), ANOVA
for three groups' comparisons, and the Mann-Whitney
test statistic (for non-parametrical comparisons). A two-
sided p-value of 0.05 was used as a criterion for statistical
significance. Multivariable regression analysis was per-
formed to detect possible prognostic determinants of the
clinical course (SPSS 8.0).
• Ethical approval: for this study design ethical approval
was not required.
Results
• Response
The study population initially consisted of 644 patients
with chronic non-specific abdominal complaints. Data
were collected in a period from 1997–1999. The GPs (n =
30) filled out and returned 628 questionnaires (97.5%).
Of these 628 patients 9 did not meet our inclusion criteria
because 8 were over 70 years of age and one was younger
than 18 years of age. These patients were excluded from
Table 1: Course of complaints for total study population and for Non Ulcer Dyspepsia (NUD), IBS and Other. (patient questionnaire 
data)
Baseline 18 months
Total 
(n = 291)
NUD 
(n = 36)
IBS 
(n = 125)
Other 
(n = 130)
Total 
(n = 230)
NUD 
(n = 29)
IBS 
(n = 95)
Other 
(n = 106)
% of patients with subjective 
improvement
55.2% 50% 44.8% 60.8% 48.3% 58.6% 43.2% 50.0%
GSRS 33.6 34.8 34.4 32.5 31.8 31.5 33.0 31.0
Norm scores*
SCL-anxiety 18.4 15.8 19.4 18.0 16.9 15.5 17.2 17.0 12
SCL-depression 26.6 22.7 28.1 26.2 25.9 23.7 26.4 26.2 20
Norm scores**
NHP-physical mobility 11.7 10.7 12.1 11.6 10.0 9.6 10.7 9.5 4.1
NHP-pain 20.3 16.1 21.5 20.3 14.7 11.0 16.2 14.3 7.0
NHP-sleep 20.9 14.8 26.4 17.4 16.1 13.4 20.3 13.1 15.2
NHP-energy 32.8 23.8 33.4 34.6 26.6 20.6 30.8 28.8 17.0
NHP-social isolation 10.2 6.3 12.4 9.3 7.8 7.2 6.9 8.7 5.3
NHP-emotional reactions 19.3 12.5 21.0 19.6 13.6 8.7 16.2 15.5 13.1
* Mean norm scores in a healthy population
** Mean norm scores: females 45–50 years of agePage 3 of 8
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Table 2: Relationship between baseline characteristics and outcome follow-up after 18 months (patient questionnaire data, N = 291)
Groups Improvementa Pain intensity Sleep (NHP) Pain (NHP) Anxiety (SCL) Depression (SCL) GSRS
% Score at 
follow-up
18 months 
change 
scored
Score at 
follow-up
18 months 
change 
scored
Score at 
follow-up
18 months 
change 
scored
Score at 
follow-up
18 months 
change 
scored
Score at 
follow-up
18 months 
change 
scored
Score at 
follow-up
18 months 
change 
scored
Age
18 to 45 47.9 3.1 -0.6** 10.8 -3.4 9.7 -5.3 16.9 -0.9 25.4 -1.1** 31.1 -3.7**
45 to 70 48.5 3.5 -0.3 19.8 -2.3 18.2 -2.0 16.9 -0.5 26.4 + 1.2 32.3 + 0.5
Sex
Male 45.8 2.8 -0.2 12.4 -3.1 10.8 -1.0 15.4 -0.4 23.4 0.0 31.0 -0.6
Female 49.7 3.6 -0.6 18.3 -2.6 16.5 -4.7 17.7 -0.9 27.4 + 0.4 32.3 -1.6
Duration
< 5 yrs. 54.5 3.2 -0.5 12.3 -3.3 12.8 -3.4 16.7 -0.9 25.5 + 0.3 30.8 -2.0
> 5 yrs. 39.6* 3.5 -0.3 20.0 -1.6 15.9 -3.3 16.9 -0.5 25.9 0.0 32.5 + 0.1
Comorbidityc
Yes 39.8 3.9 -0.3** 21.1 -4.4 19.4 -1.5 18.4 -0.5 29.0 -0.2 34.0 -1.1
No 55.7 2.8 -0.6 11.7 -0.9 10.6 -5.6 15.6 -0.9 23.2 + 0.8 29.9 -1.4
Diagnostics
Yes 51.2 3.4 -0.9 17.8 -3.3 16.6 -5.1 16.8 -1.1 26.3 -0.4 32.1 -2.6
No 35.2 3.3 0.0 14.0 -2.0 12.1 -1.2 17.0 -0.2 25.5 + 1.2 31.5 + 0.6
Interventions
Yes 50.0 3.5 -0.8 19.2 -2.2** 17.2 -5.2 17.3 -0.6 27.1 + 0.3 32.5 -2.4
No 45.2 3.1 + 0.3 10.7 -3.8 10.1 -0.1 16.2 -0.8 24.0 + 0.3 30.6 + 0.8
Referral
Yes 36.8 4.3 0.0 16.4 + 0.5 18.8 -7.3 17.6 -1.2 26.3 -1.6 36.7 + 0.1
No 50.5 3.2 -0.3 16.1 -3.4 13.8 -2.6 16.8 -0.6 25.9 + 0.7 30.9 -1.5
a. Percentage of patients that reported any improvement of their complaints at follow-up.
b. Pain intensity at follow-up as reported by the patients on an 11-point ordinal scale.
c. Comorbidity: patients who were suffering from a chronic disease other than non-specific abdominal complaints in the year before baseline and were treated for this chronic disease by their 
GP.
d. Absolute change scores; change between scores at baseline and follow-up
* p < 0.05, ** p < 0.01, both analyses based on the proportional change-score, in order to correct for differences in scores at baseline
BMC Family Practice 2006, 7:12 http://www.biomedcentral.com/1471-2296/7/12the analysis. Of these 619 patients 291 (47%) filled out
and returned the baseline questionnaire. Thus, the final
study population consisted of 619 patients with chronic
non-specific abdominal complaints, with 291 subjects
with data available from both patients and GP ("respond-
ers") and 328 subjects with data available from GP only
("non-responders").
The response rates for the GP questionnaires after 6, 12
and 18 months were 96.8%, 94.0% and 91.6%, respec-
tively. In the follow-up period of 18 months 11 patients
removed, 1 patient died, 30 patients were excluded from
the study because an organic cause was found to explain
the complaints and 10 patients were lost-to-follow-up
without known reason.
The response rates for the patient questionnaires after 6,
12 and 18 months were 83.8%, 82.8% and 79.0%, respec-
tively.
• Patient characteristics
Mean age of the responders at baseline (n = 291) was 46.4
years (SD 12.8), 34.4% were men. We reported earlier that
the non-responders were significantly more frequently
male and significantly younger, had significantly longer
duration of complaints, and paid significantly less visits to
their GP [21].
• Course of complaints
Table 1 shows the percentage of patients that report
improvement in their chronic non-specific abdominal
complaints, the mean GSRS scores, the mean scores on
the SCL scales for anxiety and depression and the mean
scores on the NHP scales, at baseline and after 18 months
of follow-up. At baseline 55.2% of the patients did report
improvement of their complaints during the previous 12
months. When asked after 18 months of follow-up this
percentage went to 48,3%. Patients with IBS and other
abdominal complaints reported less improvement than
patients with NUD. Patients with IBS scored higher on the
anxiety and depression scales than patients with NUD,
and scored worse on NHP-sleep than patients with other
abdominal complaints.
Table 2 shows that patients with long duration of com-
plaints and without comorbidity at baseline had more
improvement of their complaints at the end of the follow-
up period. Patients with comorbidity scored more unfa-
vourable on all items after follow-up. Age and sex were
not related to subjective global improvement of com-
Table 3: Diagnostic and therapeutic modalities in patients with chronic non-specific abdominal pain in general practice (reported by 
the GPs).1
Baseline 1 1/2 years
Total 
(n = 619)
NUD 
(n = 93)
IBS 
(n = 244)
Other 
(n = 282)
Total 
(n = 571)
NUD 
(n = 85)
IBS 
(n = 230)
Other 
(n = 256)
Physical examination 42.0 47.3 37.7 44.0 35.7 41.2 36.5 33.2
Laboratory examination 11.6 7.5 9.4 15.0 1.9 0.0 2.6 2.0
X-ray 5.0 3.4 4.5 5.7 3.2 1.2 2.2 4.7
Endoscopy 6.3 15.1 3.3a 6.1a 4.4 3.5 4.3 4.7
Reassurance 25.4 15.1 26.6a 27.5a 22.4 18.8 24.8 21.5
Counseling concerning psychosocial stress 9.7 7.5 10.7 9.6 8.1 9.4 8.3 7.4
Dietary advice 14.5 14.0 18.0c 11.4 10.3 5.9 14.3 8.2
Medication 50.1 66.7 44.3 49.3 35.7 40.0 34.3 35.5
Paracetamol/aspirin 4.8 5.4 4.5 5.0 4.6 4.7 5.2 3.9
Antacids 16.0 31.2b 7.0c 18.2a 9.8 10.6 7.8 11.3
Antispasmodics 18.6 14.0 23.8c 15.7 16.6 9.4b 22.2c 14.1
Laxantia 5.0 5.4 4.1 5.0 3.3 1.2 4.3 3.1
Fiber supplements 5.5 1.1b 8.6c 3.9 5.8 1.2b 7.4 5.9
Antidepressants 3.7 3.2 3.7 3.9 2.6 3.5 3.0 2.0
Proton pump inhibitors 3.9 6.5 2.0 4.6 11.0 12.9b 5.2c 15.6
H2-receptor antagonist 6.9 10.8 4.1a 7.9 12.1 17.6b 8.7 13.3
Anti emetics 2.6 3.2 1.6 3.2 3.0 5.9 2.6 2.3
Percentage of patients who underwent at least once a specific diagnostic modality or were treated at least once with one therapeutic modality 
during the twelve-month period before baseline and during the 18 months prospective follow-up.
Note that since more than one modality can be applied in one patient, the sum of the column percentages may exceed 100%.
a Significant difference with regards to NUD (p < 0.05)
b Significant difference with regards to IBS (p < 0.05)
c Significant difference with regards to Other (p < 0.05)Page 5 of 8
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age scored higher on both NHP scales sleep and pain than
patients 45 and younger. Female patients scored higher
on pain intensity, NHP-pain and SCL subscale depression
than male patients. Patients who had undergone thera-
peutic modalities scored significantly higher on both
NHP scales sleep and pain and on SCL subscale depres-
sion than patients who were not.
Furthermore, patients who were referred scored higher on
the GSRS than patients who were not referred.
When taking into consideration the proportional change
scores (not in table), younger patients scored significantly
lower on pain intensity, SCL subscale depression and
GSRS after follow-up than patients older than 45 years.
Based on the proportional change scores, patients without
comorbidity scored significantly lower on pain intensity
after follow-up than patients with comorbidity and
patients who underwent therapeutic modalities scored
significantly lower on NHP scale sleep than patients who
did not.
Multivariable regression analysis however did not show
any significant predictors of the course of chronic non-
specific abdominal complaints.
• Management of chronic non-specific abdominal 
complaints by family physicians
The GPs provided information on diagnosis, therapy and
referrals during the 18 months follow-up and over the
year previous to baseline. During the follow-up 50 per
cent of all patients visited their GP because of chronic
non-specific abdominal complaints, with a median
number of visits of 1 (range 0–14). Physical examination
was performed in 35.7% of the patients (n = 571), labora-
tory tests were done in 1.9%, X-rays were taken in 3.2%
and endoscopy was used for 4.4% of the patients (Table
3). Whereas at baseline patients with NUD underwent sig-
nificantly more endoscopies than patients with IBS or
other abdominal complaints, after 18 months of follow-
up no significant differences could be found. The largest
proportion of patients that received medication were
patients with NUD, although prescription of drugs in
NUD-patients decreases from 66.7% at baseline to 40.0%
after 18 months follow-up. The use of antacids in NUD
decreases from 31.2% at baseline to 10.6% after 18
months, whereas the use of proton pump inhibitors dou-
bles during follow-up (6.5% at baseline vs 12.9% after 18
months). Also the use of H2-receptor antagonists in NUD
patients increases during follow-up (10.8% at baseline vs.
17.6% after 18 months). A similar pattern is seen in both
other subgroups; the prescription of proton pump inhibi-
tors and H2-receptor antagonists doubled after 18
months follow-up, although the use of both types of med-
ication is significantly higher for NUD patients than for
IBS patients. In the total population antispasmodics, pro-
ton pump inhibitors and H2-receptor antagonists were
the most frequently used medication (16.6%, 11.0% and
12.1% respectively after 18 months). Only 9.3% of the
patients were referred to secondary care by the GP during
the 18 months follow-up period. The gastroenterologist is
the specialist to whom most patients were referred.
Discussion
The aim of this study was to provide data on management
and course of complaints of chronic non-specific abdom-
inal pain in primary care. In this study, it was shown that
after 18 months of follow-up 48.3% of the patients stated
that their complaints have improved: in the NUD group
this was 58.6% while in the IBS group this was 43.2%. In
a previous review on the clinical course of NUD [9] we
reported that for studies with a follow-up of 2 years or less
the mean symptomatic improvement was 42.7% in NUD
patients. In a review on the clinical course of IBS the
improvement rate for IBS patients in studies with a fol-
low-up of 3 years or less was 57% [8]. However, none of
these studies has been done in general practice. This
implies that in general, a substantial proportion of
patients with chronic complaints about NUD and IBS in
general practice show persistence of the symptoms over
time. However it should be pointed out here that our
results are applicable only to patients with already chronic
disorders, and are invalid for all patients with IBS, NUD
of FGID.
In our study, all patients showed anxiety and depression
scores above norm scores, both at baseline and after fol-
low-up. Patients with NUD had the lowest levels of anxi-
ety and depression symptoms compared to patients with
IBS and patients with other abdominal complaints.
The general health status of patients with chronic non-
specific abdominal complaints was impaired at baseline
and stayed almost unchanged after follow-up. Patients
with IBS had a more impaired quality of life on all dimen-
sions of the NHP than the other patients, and continued
to have more impaired quality of life at the end of follow-
up.
Information on the clinical course of chronic non-specific
abdominal complaints was derived from the patient ques-
tionnaires, which were returned by 47% of the patients
(after sending two reminders). This may imply that there
is selection bias. Therefore we compared baseline charac-
teristics and found differences on some potentially rele-
vant patient characteristics between responding and non-
responding patients. Responders had significantly shorter
duration of complaints at the beginning of the study and
visited the GP significantly more often than non-respond-Page 6 of 8
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may suggest that the responding patients comprise a sub-
group of patients who more often actually suffered from
their abdominal complaints at the moment they were
asked to participate in this study. Non-responders possi-
bly would have responded differently on questions on
characteristics of complaints, general health perception
and psychological assessment. We did not perform a non-
response analysis at 18 months, but a similar bias may be
present here.
Therefore, results regarding the clinical course of the com-
plaints should be interpreted with some reservation. Nev-
ertheless, because the entire study population, responders
as well as non-responders, was used in describing the
management of chronic non-specific abdominal com-
plaints, the non-response did not have consequences for
our estimates of the frequencies of the use of diagnostic
modalities, therapeutic interventions and referrals.
After 18 months of follow-up we found that diagnostic
investigations were not often used much. The diagnostic
modality most often used was physical examination,
whereas more expensive investigations like laboratory, X-
ray, and endoscopic examination were used less fre-
quently. Diagnostic modalities were most frequently
applied in the group of patients with abdominal com-
plaints, other than NUD and IBS. This may suggest that
after the diagnostic procedure, there is less diagnostic
uncertainty by the GPs during the follow-up of patients
with NUD and IBS. Reassurance was still a frequently used
therapy after 18 months of follow-up, especially in
patients with IBS. This is in accordance with the current
clinical guidelines for the management of IBS [22]. After
18 months of follow-up, medication was still prescribed
in 35.7% of the patients. In patients with NUD the use of
antacids was decreased whereas the use of proton pump
inhibitors was increased. When taking into consideration
that in IBS patients no single drug has been shown to be
effective [23], a high proportion of patients still uses med-
ication after 18 months follow-up.
In the follow-up period only 9.3% of the patients were
referred to secondary or tertiary care. In case of referral, the
gastroenterologist was the specialist most frequently
referred to.
Our study population consisted of prevalent cases of
chronic non-specific abdominal complaints. The patients
had a mean duration of complaints of 5.2 years (range 1
to 41 years) at baseline. During follow-up no spectacular
changes in the course of the complaints took place. In the
bivariate analysis age, duration of complaints, comorbid-
ity and appliance of therapeutic modalities seemed to be
possible prognostic determinants. Since one of the aims
of this study was to identify prognostic determinants of
the course of the complaints, we planned to use a logistic
regression model to investigate the association between
the outcome measures improvement, NHP-subscales,
SCL-subscales and GSRS and the various possible prog-
nostic determinants. However, the data for the total
cohort and several subgroups only showed small differ-
ences after follow-up, and multivariable logistic regres-
sion analysis did not show any significant prognostic
determinants of the course of chronic non-specific
abdominal complaints.
Conclusion
This study shows that chronic non-specific abdominal
complaints have a serious impact on the patients. The
Table 4: Number of new referrals to medical specialists and allied care in patients with chronic non-specific abdominal complaints, as 
reported by the GPs.1
Baseline 18 months
Total 
(n = 619)
NUD 
(n = 93)
IBS 
(n = 244)
Other 
(n = 282)
Total 
(n = 571)
NUD 
(n = 85)
IBS 
(n = 230)
Other 
(n = 256)
No referral 88.8 89.2 91.0 86.6 90.7 92.9 90.4 90.2
Gastroenterologist 6.6 6.5 6.1 7.1 5.3 2.4 5.7 5.9
Social worker 0.6 0.0 0.0 1.4 0.6 1.2 0.4 0.4
Dietician 0.5 1.1 0.0 0.7 0.9 0.0 0.9 1.2
Psychologist 1.1 2.2 1.6 0.4 0.7 0.0 0.9 0.8
Gynaecologist 1.6 0.0 1.2 2.5 0.5 0.0 0.4 0.8
Surgeon 0.5 1.1 0.4 0.4 0.9 1.2 1.7 0.0
Other 1.1 1.1 0.8 1.2 1.1 2.4 0.4 1.2
Percentage of patients who were referred at least once to a specific specialist during the twelve-month period before baseline and during the 1 1/2 
years prospective follow-up. Note that since more than one modality can be applied in one patient, the sum of the column percentages may exceed 
100%Page 7 of 8
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health perception is clearly impaired and patients show
high scores of anxiety and depression.
Since only few patients were referred to secondary or terti-
ary care, the GPs in our study seem to handle most of the
patients with chronic non-specific abdominal complaints.
Relatively few diagnostic investigations were carried out.
This suggests that once the diagnosis is determined, no
indications for further investigations are found.
GPs prescribed relatively many drugs. There is a clear need
for further evaluation of guidelines for management of
chronic non-specific abdominal complaints and studies
to investigate the implementation of these guidelines.
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